{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2019"],"data_sharing_plan":["IPD Sharing (as of April 2019): No"],"condition":["Colorectal Cancer","Colorectal Neoplasms"],"disease":["Colorectal Cancer","Colorectal Neoplasms"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2303689"],"location":["Egypt"],"study_start_month":["4"],"keyword":["Mebendazole","Piperazine citrate","Piperazine","DMP 777","Bevacizumab"],"repository":["ECRIN MDR"],"study_status":["Recruiting"],"additional_accession":[]},"is_claimable":false,"name":"Mebendazole as Adjuvant Treatment for Colon Cancer","description":"mebendazole treating colon cancer","dates":{"creation":"2019-04-15"},"accession":"2303689","cross_references":{"ClinicalTrials___gov":["NCT03925662"]}}